Assessing ovarian response: antral follicle count versus anti-Müllerian hormone

Richard Fleming, David Seifer, John L. Frattarelli, Jane Ruman

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

Oocyte number and quality decline with age; however, fertility varies significantly even among women of the same age. Various measures have been developed to predict response to ovarian stimulation and reproductive potential. Evaluation of ovarian reserve can identify patients who may experience poor response or hyper-response to exogenous gonadotrophins and can aid in the personalization of treatment to achieve good response and minimize risks. In recent years, two key methods, antral follicle count (AFC), an ultrasound biomarker of follicle number, and the concentration of serum anti-Müllerian hormone (AMH), a hormone biomarker of follicle number, have emerged as preferred methods for assessing ovarian reserve. In this review, a live debate held at the American Society for Reproductive Medicine 2013 Annual Meeting is expanded upon to compare the predictive values, merits, and disadvantages of AFC and AMH level. An ovarian reserve measure without limitations has not yet been discovered, although both AFC and AMH have good predictive value. Published evidence, however, as well as the objectivity and potential standardization of AMH level and the convenience of testing any time throughout the menstrual cycle, leans towards AMH level becoming the gold-standard biomarker to evaluate ovarian reserve and predict ovarian response to stimulation.

Original languageEnglish (US)
Article number1391
Pages (from-to)486-496
Number of pages11
JournalReproductive BioMedicine Online
Volume31
Issue number4
DOIs
StatePublished - Oct 1 2015

Fingerprint

Hormones
Biomarkers
Ovulation Induction
Menstrual Cycle
Gonadotropins
Gold
Oocytes
Fertility
Antral
Ovarian Reserve
Serum
Therapeutics

Keywords

  • anti-Müllerian hormone
  • antral follicle count
  • hyper-response
  • in-vitro fertilization
  • ovarian reserve
  • poor response

ASJC Scopus subject areas

  • Reproductive Medicine
  • Developmental Biology

Cite this

Assessing ovarian response : antral follicle count versus anti-Müllerian hormone. / Fleming, Richard; Seifer, David; Frattarelli, John L.; Ruman, Jane.

In: Reproductive BioMedicine Online, Vol. 31, No. 4, 1391, 01.10.2015, p. 486-496.

Research output: Contribution to journalArticle

Fleming, Richard ; Seifer, David ; Frattarelli, John L. ; Ruman, Jane. / Assessing ovarian response : antral follicle count versus anti-Müllerian hormone. In: Reproductive BioMedicine Online. 2015 ; Vol. 31, No. 4. pp. 486-496.
@article{9564accef2c64333a662ece0a87b772a,
title = "Assessing ovarian response: antral follicle count versus anti-M{\"u}llerian hormone",
abstract = "Oocyte number and quality decline with age; however, fertility varies significantly even among women of the same age. Various measures have been developed to predict response to ovarian stimulation and reproductive potential. Evaluation of ovarian reserve can identify patients who may experience poor response or hyper-response to exogenous gonadotrophins and can aid in the personalization of treatment to achieve good response and minimize risks. In recent years, two key methods, antral follicle count (AFC), an ultrasound biomarker of follicle number, and the concentration of serum anti-M{\"u}llerian hormone (AMH), a hormone biomarker of follicle number, have emerged as preferred methods for assessing ovarian reserve. In this review, a live debate held at the American Society for Reproductive Medicine 2013 Annual Meeting is expanded upon to compare the predictive values, merits, and disadvantages of AFC and AMH level. An ovarian reserve measure without limitations has not yet been discovered, although both AFC and AMH have good predictive value. Published evidence, however, as well as the objectivity and potential standardization of AMH level and the convenience of testing any time throughout the menstrual cycle, leans towards AMH level becoming the gold-standard biomarker to evaluate ovarian reserve and predict ovarian response to stimulation.",
keywords = "anti-M{\"u}llerian hormone, antral follicle count, hyper-response, in-vitro fertilization, ovarian reserve, poor response",
author = "Richard Fleming and David Seifer and Frattarelli, {John L.} and Jane Ruman",
year = "2015",
month = "10",
day = "1",
doi = "10.1016/j.rbmo.2015.06.015",
language = "English (US)",
volume = "31",
pages = "486--496",
journal = "Reproductive BioMedicine Online",
issn = "1472-6483",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - Assessing ovarian response

T2 - antral follicle count versus anti-Müllerian hormone

AU - Fleming, Richard

AU - Seifer, David

AU - Frattarelli, John L.

AU - Ruman, Jane

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Oocyte number and quality decline with age; however, fertility varies significantly even among women of the same age. Various measures have been developed to predict response to ovarian stimulation and reproductive potential. Evaluation of ovarian reserve can identify patients who may experience poor response or hyper-response to exogenous gonadotrophins and can aid in the personalization of treatment to achieve good response and minimize risks. In recent years, two key methods, antral follicle count (AFC), an ultrasound biomarker of follicle number, and the concentration of serum anti-Müllerian hormone (AMH), a hormone biomarker of follicle number, have emerged as preferred methods for assessing ovarian reserve. In this review, a live debate held at the American Society for Reproductive Medicine 2013 Annual Meeting is expanded upon to compare the predictive values, merits, and disadvantages of AFC and AMH level. An ovarian reserve measure without limitations has not yet been discovered, although both AFC and AMH have good predictive value. Published evidence, however, as well as the objectivity and potential standardization of AMH level and the convenience of testing any time throughout the menstrual cycle, leans towards AMH level becoming the gold-standard biomarker to evaluate ovarian reserve and predict ovarian response to stimulation.

AB - Oocyte number and quality decline with age; however, fertility varies significantly even among women of the same age. Various measures have been developed to predict response to ovarian stimulation and reproductive potential. Evaluation of ovarian reserve can identify patients who may experience poor response or hyper-response to exogenous gonadotrophins and can aid in the personalization of treatment to achieve good response and minimize risks. In recent years, two key methods, antral follicle count (AFC), an ultrasound biomarker of follicle number, and the concentration of serum anti-Müllerian hormone (AMH), a hormone biomarker of follicle number, have emerged as preferred methods for assessing ovarian reserve. In this review, a live debate held at the American Society for Reproductive Medicine 2013 Annual Meeting is expanded upon to compare the predictive values, merits, and disadvantages of AFC and AMH level. An ovarian reserve measure without limitations has not yet been discovered, although both AFC and AMH have good predictive value. Published evidence, however, as well as the objectivity and potential standardization of AMH level and the convenience of testing any time throughout the menstrual cycle, leans towards AMH level becoming the gold-standard biomarker to evaluate ovarian reserve and predict ovarian response to stimulation.

KW - anti-Müllerian hormone

KW - antral follicle count

KW - hyper-response

KW - in-vitro fertilization

KW - ovarian reserve

KW - poor response

UR - http://www.scopus.com/inward/record.url?scp=84943582082&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943582082&partnerID=8YFLogxK

U2 - 10.1016/j.rbmo.2015.06.015

DO - 10.1016/j.rbmo.2015.06.015

M3 - Article

C2 - 26283017

AN - SCOPUS:84943582082

VL - 31

SP - 486

EP - 496

JO - Reproductive BioMedicine Online

JF - Reproductive BioMedicine Online

SN - 1472-6483

IS - 4

M1 - 1391

ER -